Health product recalls and alerts, 2004
109 notices, newest first. Each links to the official notice.
Drugs, vaccines and biologics
- Archived – Warning not to use Lot 4G03 Artificial Tears ExtraDecember 23, 2004 · Drugs · Contamination
- Important Safety Information on CELEBREX (Celecoxib): Increased Cardiovascular Risk – For Health ProfessionalsDecember 22, 2004 · Drugs · Product safety
- Archived – Safety information regarding selective COX-2 inhibitor NSAIDs: Vioxx, (rofecoxib), Celebrex (celecoxib), Bextra (valdecoxib), Mobicox (meloxicam) and generic forms of meloxicamDecember 22, 2004 · Drugs · Labelling
- Archived – Medication Errors Involving Reminyl and Amaryl – Janssen-Ortho Inc. and Aventis Pharma Inc.December 21, 2004 · Drugs · Product safety
- Archived – Medication Errors Involving REMINYL and AMARYL® – Janssen-Ortho Inc. and Aventis Pharma Inc.December 21, 2004 · Drugs · Product safety
- Archived – Medication Errors Involving Reminyl and Amaryl –Janssen-Ortho Inc. and Aventis Pharma Inc.December 21, 2004 · Drugs · Product safety
- Archived – Updated safety information on increased cardiovascular risk with Celebrex (celecoxib)December 17, 2004 · Drugs
- Updated Safety Information: Possible Relationship of Aredia and/or Zometa with Osteonecrosis of the Jaw – For Health ProfessionalsDecember 15, 2004 · Drugs · New safety information
- Archived - Updated safety: Possible relationship of Aredia and/or Zometa with osteonecrosis of the jaw - Novartis Pharma Canada Inc. - For The PublicDecember 15, 2004 · Drugs
- Bextra (valdecoxib) - Cardiovascular Risks and Serious Skin Reactions - For Health ProfessionalsDecember 10, 2004 · Drugs
- Archived – Pfizer Canada Inc. Issues Warnings about Bextra – Cardiovascular Risks and Serious Skin Reactions – Pfizer Canada Inc. – For The PublicDecember 10, 2004 · Drugs · Product safety
- Archived - Update on Safety Information on the LTV Series Ventilators -Pulmonetic Systems, Inc.December 7, 2004 · Drugs
- Archived – Health Canada warns Canadians that certain lots of a sedative (Novo-Lorazem) may contain pills of a different drugDecember 3, 2004 · Drugs
- Archived – Updated Safety Information Addressing the Risk of Malignancies Associated with REMICADE (Infliximab) – Schering Canada Inc. – For the PublicDecember 2, 2004 · Biologic or vaccine · Product safety
- Archived – Updated Safety Information Addressing the Risk of Malignancies Associated with REMICADE (Infliximab) – Schering Canada Inc.December 2, 2004 · Biologic or vaccine · Product safety
- Archived – Updated safety information regarding CrestorNovember 24, 2004 · Drugs
- Archived – Important Safety Update: Potential Effect of DEPO-PROVERA (Medroxyprogesterone Acetate) on Bone Mineral DensityNovember 22, 2004 · Drugs · Product safety
- Archived – Obligations of Pharmacists under the Food and Drugs Act and Food and Drug RegulationsNovember 16, 2004 · Drugs · New safety information
- Drug stability failure of a few lots of Carbolith® 150 mg capsules - For Health ProfessionalNovember 4, 2004 · Drugs
- Archived – Health Canada advises consumers to consult with their physicians on the use of Carbolith 150 milligram productsOctober 29, 2004 · Drugs · New safety information
- Archived – New Safety Information Regarding PERMAX and Occurrence of Cardiac Valvulopathy / Fibrosis – Shire BioChem Inc.October 26, 2004 · Drugs · Product safety
- Archived – New Warnings about Parkinson's Drug PERMAX® and Reports of Heart Valve Problems – Shire BioChem Inc. – For the PublicOctober 26, 2004 · Drugs · Product safety
- Archived – Update on Euro-K Recall Lot EKT 404 and Lot EKT 405 – Letter to PharmacistOctober 21, 2004 · Drugs · New safety information
- Archived – Association of EPREX (Epoetin Alfa) with Thrombotic Vascular Events – Janssen-Ortho Inc. – For the PublicOctober 18, 2004 · Biologic or vaccine · Product safety
- Archived – Association of EPREX (Epoetin Alfa) with Thrombotic Vascular Events – Janssen-Ortho Inc.October 14, 2004 · Biologic or vaccine · Product safety
- Archived – Merck Sharp & Dohme (MSD) Announces Voluntary Worldwide Withdrawal of VIOXX® (Rofecoxib) – Merck Frosst Canada LtdOctober 7, 2004 · Drugs · New safety information
- Archived – Merck Sharp & Dohme (MSD) Announces Voluntary Worldwide Withdrawal of VIOXX® (rofecoxib) – Merck Frosst Canada LtdOctober 7, 2004 · Drugs · New safety information
- Archived – Health Canada informs Canadians of Vioxx withdrawal by Merck & Co.September 30, 2004 · Drugs
- Archive – Safety and regulatory information regarding Celebrex (celecoxib), Bextra (valdecoxib), and Meloxicam subsequent to the withdrawl of Vioxx (rofecoxib)September 30, 2004 · Drugs · New safety information
- Archive – Frequently Asked Questions – Vioxx Recall By MerckSeptember 30, 2004 · Drugs
- Archived – Important Safety Information for Patients Taking LAMICTAL (Lamotrigine) – GlaxoSmithKline Inc.September 27, 2004 · Drugs · Product safety
- Archived – Important Safety Information for Patients Taking LAMICTAL (lamotrigine) – GlaxoSmithKline Inc. – For the PublicSeptember 27, 2004 · Drugs · Product safety
- Archived – Health Canada Advises Consumers to Return Euro-K and Riva-K Potassium Chloride ProductsSeptember 2, 2004 · Drugs · Product quality
- Archived – Important Safety Information on Euro-K and Riva-K Sustained Release Potassium SupplementsSeptember 1, 2004 · Drugs · Product safety
- Archived – Health Canada advises of potential adverse effects of SSRIs and other anti-depressants on newbornsAugust 9, 2004 · Drugs · New safety information
- Archived – Possible Association of RITUXAN (Rituximab) with Hepatitis B Reactivation – Hoffmann-La Roche LimitedJuly 30, 2004 · Biologic or vaccine · Product safety
- Archived – Possible Association Between RITUXAN® (Rituximab) and the Recurrence of Hepatitis B – Hoffmann-La Roche Limited – For the PublicJuly 30, 2004 · Biologic or vaccine · Product safety
- Archived – Association of DESYREL (Trazodone) with Drug Interactions with Medications that Alter CYP 3A4 MetabolismJuly 8, 2004 · Drugs · Product safety
- Archived - Health Canada Is Advising Canadians That Antidepressant Trazodone May Interact with Certain MedicationsJuly 8, 2004 · Drugs
- Archived – Product Recall Notice PROGLYCEM Suspension – Schering Canada Inc.July 2, 2004 · Drugs · Product safety
- Archived - Health Canada Advises Consumers Not to Ingest Teas or Health Products Containing Star Anise Unless it Is Identified as Chinese Star AniseJune 29, 2004 · Drugs
- Possibility of Sensitization to CIDEX OPA Solution with Repeated Exposure – For Health ProfessionalsJune 24, 2004 · Drugs · Product safety
- Archived – ARAVA (Leflunomide) and Lung Inflammation Causing Difficulty Breathing – For the PublicJune 24, 2004 · Drugs · Product safety
- ARAVA (Leflunomide) and Interstitial Lung Disease – For Health ProfessionalsJune 24, 2004 · Drugs · Product safety
- Health Canada Releases Important Information on the Dispensation of CLOZAPINE Products in Canada – Notice to HospitalsJune 23, 2004 · Drugs · Product safety
- Health Canada releases important information on the dispensation of CLOZAPINE products in Canada - For Health ProfessionalsJune 23, 2004 · Drugs
- Archived - Health Canada Takes Additional Safety Measures to Ensure the Safe Use of ClozapineJune 23, 2004 · Drugs
- Archived - Health Canada is warning Canadians to discard “BABY” / “BÉBÉ” brand pacifiers sold at Dollarama storesJune 23, 2004 · Drugs
- Archived – Important Safety Information Regarding the Association Between CRESTOR (Rosuvastatin) and RhabdomyolysisJune 22, 2004 · Drugs · Product safety
- Archived – Health Canada Endorsed Important Safety Information on PRE-PEN® (Benzylpenicilloyl Polylysine Injection USP) DIN: 00328693June 18, 2004 · Drugs · Product safety
- Archived - Health Canada advises health professionals and consumers about penicillin allergy test recallJune 18, 2004 · Drugs
- Archived – Important Drug Safety Information for WELLBUTRIN® SR and ZYBAN® (Bupropion HCI): Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-HarmJune 10, 2004 · Drugs · Product safety
- Archived – Bronchial Problems Associated with Rapamune® (Sirolimus) – For the PublicJune 5, 2004 · Drugs · Product safety
- Archived - Health Canada is advising health professionals and patients regarding the recall of specific batches of ProglycemJune 4, 2004 · Drugs
- Archived - Health Canada advises Canadians of stronger warnings for SSRIs and other newer anti-depressantsJune 3, 2004 · Drugs
- Archived – Important Drug Safety Information for ZOLOFT: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-HarmJune 2, 2004 · Drugs · Product safety
- Archived – Important Drug Safety Information for LUVOX: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-HarmJune 2, 2004 · Drugs · Product safety
- Archived – Important Drug Safety Information for Paroxetine: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-HarmJune 2, 2004 · Drugs · Product safety
- Important Drug Safety Information for REMERON RDTM/REMERON® : Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-HarmJune 2, 2004 · Drugs · Product safety
- Archived – Important Drug Safety Information for Prozac: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-HarmJune 2, 2004 · Drugs · Product safety
- Important Drug Safety Information for CELEXA: Warning for SSRIs and Other Newer Anti-Depressants Regarding the Potential for Behavioural and Emotional Changes, Including Risk of Self-HarmJune 2, 2004 · Drugs · Product safety
- Archived - Outbreak of Gastrointestinal Illness at Emerald Lake Lodge, Yoho National ParkMay 28, 2004 · Drugs · Contamination
- Archived - Outbreak of Gastrointestinal Illness at Emerald Lake Lodge, Yoho National Park - UpdatedMay 28, 2004 · Drugs · Contamination
- Health Canada warns Canadians not to use “Thermonex”May 28, 2004 · Drugs
- Archived - Health Canada warns public not to use Bell Magnum BulletMay 21, 2004 · Drugs · Unauthorized product
- Archived – Important New Safety Information on ORTHOCLONE OKT*3 (Muromonab-CD3) – For the PublicMay 17, 2004 · Biologic or vaccine · Product safety
- Archived – Serious Adverse Reactions in Pediatric Patients Treated with ORTHOCLONE OKT*3 (muromonab-CD3) – Notice to HospitalsMay 13, 2004 · Biologic or vaccine · Product safety
- Archived – Emerging Safety Information: Diarrhea and Ischemic Colitis in Patients Using ZELNORM (Tegaserod Hydrogen Maleate) – Novartis Pharmaceuticals Canada Inc. – For the PublicMay 13, 2004 · Drugs · Product safety
- Archived – Conditional Approval of Viread (Tenofovir Disoproxil Fumarate) – Gilead Sciences, Inc.May 10, 2004 · Health products · Product safety
- Archived – Important Safety Update: Diarrhea and Ischemic Colitis in Patients Using ZELNORM (Tegaserod Hydrogen Maleate)May 6, 2004 · Drugs · Product safety
- Important Safety Information Regarding Reports of Serious Hepatic Events in Patients Receiving ACCOLATE® (Zafirlukast) – For Health ProfessionalsApril 19, 2004 · Drugs · Product safety
- Archived – Important Safety Information Concerning Liver Problems for Patients Taking ACCOLATE® (Zafirlukast) – AstraZeneca Canada Inc. – For the PublicApril 19, 2004 · Drugs · Product safety
- Archived - Health Canada is advising Canadians about the potential risks to health posed by vermiculite insulation that may contain asbestosApril 3, 2004 · Drugs
- Archived – Updated Safety Information for ZYPREXA (Olanzapine) in Elderly Dementia Patients, Announced in Canada – Eli Lilly Canada Inc. – For the PublicMarch 18, 2004 · Drugs · Product safety
- Archived – Important Drug Safety Information: ZYPREXA (olanzapine) and Cerebrovascular Adverse Events in Placebo-Controlled Elderly Dementia TrialsMarch 17, 2004 · Health products · Product safety
- Archived – Important New Safety Information Clarifying Risk Factors for Severe, Life-threatening and Fatal Hepatotoxicity with VIRAMUNE® (Nevirapine)March 12, 2004 · Health products · Product safety
- Archived – Association of Tazocin® (Piperacillin/Tazobactam) with False Positive Results of the Bio-Rad Aspergillus AssayMarch 9, 2004 · Drugs · Product safety
- Archived – Important Safety Information Regarding the Antiparkinson Drug PERMAX® (Pergolide Mesylate): Sudden Onset of SleepFebruary 17, 2004 · Drugs · Product safety
- Archived – Important Safety Information Regarding TAMIFLU® (Oseltamivir Phosphate) and Prescription in Children Less Than One Year of AgeFebruary 9, 2004 · Drugs · Product safety
- Archived - Correction: Health Canada advises Canadians under the age of 18 to consult physicians if they are being treated with newer anti-depressantsFebruary 3, 2004 · Drugs
- Archived – Information for Patients Regarding a Drug Interaction Between RITONAVIR (Norvir/Kaletra) and FLUTICASONE Propionate (Flonase, Flovent, Advair) – GlaxoSmithKline Inc. – For the PublicFebruary 2, 2004 · Drugs · Product safety
- Archived - Health Canada advises Canadians under the age of 18 to consult physicians if they are being treated with newer anti-depressantsFebruary 2, 2004 · Drugs
- Archived – Important Safety Information Regarding a Drug Interaction Between Fluticasone Propionate (Flonase /Flovent /Advair ) and Ritonavir (Norvir /Kaletra )January 30, 2004 · Drugs · Product safety
- Archived – Updated Safety Information Announced in Canada for Patients Taking TOPAMAX (Topiramate) Regarding Higher than Normal Blood Acid Levels – Janssen-Ortho Inc. – For the PublicJanuary 26, 2004 · Drugs · New safety information
- Archived – TOPAMAX (topiramate) Use is Associated with Metabolic AcidosisJanuary 21, 2004 · Drugs · Product safety
- Archived – Updated Safety Information about EPREX (Epoetin Alfa) Provided to Canadian Healthcare Professionals – For The PublicJanuary 15, 2004 · Biologic or vaccine · New safety information
- Archived – Important Drug Safety Information: EPREX (Epoetin Alfa) Sterile Solution: Revised Prescribing Information for Patients with Chronic Renal FailureJanuary 15, 2004 · Biologic or vaccine · New safety information
- Archived – Serious Liver Injury with TEBRAZID (Pyrazinamide) or PMS-pyrazinamide and Rifampin for the Treatment of Latent Tuberculosis – ICN Canada Limited and Pharmascience Inc. – For the PublicJanuary 6, 2004 · Drugs · Product safety
- Archived - Serious liver injury with TEBRAZID (pyrazinamide) or PMS-pyrazinamide and rifampin for the treatment of latent tuberculosis - ICN Canada Limited and Pharmascience Inc.January 1, 2004 · Drugs
- Archived - Important drug safety information for EFFEXOR®: Warning for SSRIs and other newer anti-depressants regarding the potential for behavioural and emotional changes, including risk of self-harmJanuary 1, 2004 · Drugs
Natural health products
- Archived – Health Canada warns consumers not to use Male Power PlusNovember 26, 2004 · Natural health products · Undeclared substance - Unauthorized product
- Archived – Health Canada advises consumers not to use the products containing Aristolochic AcidJuly 26, 2004 · Natural health products
- Archived – Health Canada Warns Canadians Not to Use Sesa Hair SupplementJuly 23, 2004 · Natural health products · Undeclared substance
Medical devices
- Archived – Serious Risk of Infection From Ultrasound and Medical Gels – RevisionDecember 16, 2004 · Medical devices · Product safety
- Archived – Urgent Product Removal Oral-B CrossAction Power and PowerMAX Toothbrushes and Refills – Updated 2004-11-30 – For the PublicNovember 30, 2004 · Medical devices · New safety information
- Archived – Recall Notification for All Unused Advanced Bionics Implantable Cochlear Stimulators – Advanced BionicsNovember 9, 2004 · Medical devices · Product safety
- Archived – Notification to CLARION CII Cochlear Implant Users – Advanced Bionics – For the PublicNovember 9, 2004 · Medical devices · Product safety
- Archived – Notification to HiRes 90K Cochlear Implant Users – Advanced Bionics – For the PublicNovember 9, 2004 · Medical devices · Product safety
- Archived – Notification to CLARION 1.2 Cochlear Implant Users – Advanced Bionics – For the PublicNovember 9, 2004 · Medical devices · Product safety
- Archived – Safety Information on the LTV Series Ventilators – Pulmonetic Systems – For the PublicNovember 4, 2004 · Medical devices · Product safety
- Archived – Urgent Product Removal Oral-B CrossAction Power and PowerMAX Toothbrushes and Refills – For the PublicOctober 29, 2004 · Medical devices · Product safety
- Archived – Risk of Serious Infection From Ultrasound and Medical Gels – Notice to HospitalsOctober 20, 2004 · Medical devices · Product safety
- Archived – Mallinckrodt, a Division of Nellcor/Tyco Healthcare Issues Recall of TracheoSoft XLT Extended Length Tracheostomy Tube – Tyco Healthcare – For the PublicAugust 20, 2004 · Medical devices · Product safety
- Archived – Important Safety Information on Hemodialysis Units and Blood Tubing Sets Incorporating a Transducer Protector – Notice to HospitalsJune 11, 2004 · Medical devices · Product safety
- Archived – Association of Absorbable Hemostatic Agents with Paralysis or Other Neural Deficits – Notice to HospitalsMay 7, 2004 · Medical devices · Product safety
- Inadequate Cleaning or Sterilization of EZ Clean Monobloc ACETABULAR REAMER – Notice to HospitalsApril 23, 2004 · Medical devices · Product safety
- Archived – Health Risks Associated with Use of INFUSION PUMPS – Notice to HospitalsApril 16, 2004 · Medical devices · Product safety
- Archived – Important Safety Information Regarding the Use of SEVORANE AF (Sevoflurane) in Conjunction with Anesthesia MachinesJanuary 8, 2004 · Drugs - Medical devices · Product safety
- Archived - Recall TAXUS Express Coronary Stent Systems and Express Coronary Stent Systems - Boston ScientificJanuary 1, 2004 · Medical devices